A comparative study of immunomodulation produced by in vitro exposure to delta opioid receptor agonist peptides

Peptides

Volumn 17, Issue 1, 1996, Pages 75-81

  House, Robert V ^a   Thomas, Peter T ^a   Bhargava, Hemendra N ^b  

^a IIT RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Delta opioid receptors; Enkephalins; Immunomodulation; Natural killer cells; Opioid peptides; T cells

Indexed keywords

CYTOKINE; DELTA OPIATE RECEPTOR; DELTAKEPHALIN; DELTORPHIN; ENKEPHALIN DERIVATIVE; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; INTERLEUKIN 6; LEUCINE ENKEPHALIN[2 DEXTRO SERINE 6 THREONINE]; OPIATE AGONIST;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; IMMUNOMODULATION; LYMPHOCYTE; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0030067757     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0196-9781(95)02051-9     Document Type: Article

References (15)

1. Chukwuocha, R. U.; Reyes, E.; Tokuda, S. The in vivo effect of opioid peptides on the murine immune response. Int. J. Immunopharmacol. 16:205-215; 1994.
2. Gillis, S.; Ferm, M. M.; Ou, W.; Smith, K. A. T cell growth factor: Parameters of production and a quantitative microassay for activity. J. Immunol. 120:2027-2032; 1978.
3. Hirano, T. Interleukin-6 and its relation to inflammation and disease. Clin. Immunol. Immunopathol. 62:S60-S65; 1992.
4. House, R. V.; Thomas, P. T.; Bhargava, H. N. Comparison of immune functional parameters following in vitro exposure to natural and synthetic amphetamines. Immunopharmacol. Immunotoxicol. 16:1-21; 1994.
5. House, R. V.; Thomas, P. T.; Bhargava, H. N. Selective modulation of immune function resulting from in vitro exposure to methylene-dioxymethamphetamine (Ecstasy). Toxicology 96:59-69; 1995.
6. Hu-Li, J.; Ohara, J.; Watson, C.; Tsang, W.; Paul, W. E. Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and an IL-2 hyporesponsive mutant of that line (CT.4S). J. Immunol. 142:800-807; 1989.
7. 6] enkephalin (DALCE) and naltrindole 5′-isothiocyanate (5′-NTII): Evidence for δ receptor subtypes. J. Pharmacol. Exp. Ther. 257:1069-1075; 1991.
8. Kraut, R. P.; Greenberg, A. H. Effects of endogenous and exogenous opioids on splenic natural killer cell activity. Nat. Immun. Cell Growth Regul. 5:28-40; 1986.
9. Mazumder, S.; Nath, I.; Dhar, M. M. Immunomodulation of human T cell responses with receptor selective enkephalins. Immunol. Lett. 35:33-38; 1993.
10. Rogers, T. J.; Taub, D. D.; Eisenstein, T. K.; Geller, E. B.; Adler, M. W. Immunomodulatory activity of kappa-, mu-, and delta-selective opioid compounds. NIDA Res. Monogr. 105:82-88; 1991.
11. Sofuoglu, M.; Portoghese, P. S.; Takemori, A. E. Differential antagonism of delta opioid agonists by naltrindole (NTI) and its benzofuran analog (NTB) in mice: Evidence for delta opioid receptor subtypes. J. Pharmacol. Exp. Ther. 257:676-680; 1991.
12. Thomas, P. T.; House, R. V.; Bhargava, H. N. Phencyclidine exposure alters in vitro cellular immune response parameters associated with host defense. Life Sci. 53:1417-1427; 1994.
13. Thomas, P. T.; House, R. V.; Bhargava, H. N. Direct cellular immunomodulation produced by diacetylmorphine (heroin) or methadone. Gen. Pharmacol. 26:123-130; 1995.
14. 2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc. Natl. Acad. Sci. USA 83:9679-9683; 1986.
15. Whiteside, T. L.; Herberman, R. B. Role of human natural killer cells in health and disease. Clin. Diag. Lab. Immunol. 1:125-133; 1994.